Department of Health and Human Services' logo Department of Health and Human Services

Public Health Service
Food and Drug Administration

 

Seattle District
Pacific Region
Bothell, WA 98021-4421
Telephone: 425-486-8788

February 8, 2005

CERTIFIED MAIL
RETURN RECEIPT REQUESTED

In reply refer to Warning Letter SEA 05-14

Donald L. Smyth, President
R-Garden Inc., and
Rose Creek Health Products, Inc.
14 Enzyme Lane
Kettle Falls, Washington 99141

WARNING LETTER

Dear Mr. Smyth:

The Food and Drug Administration (FDA) inspected your firms located at 14 Enzyme Lane, Kettle Falls, Washington, on October 26-28, 2004. During the inspection our investigator collected information, including product labeling and copies of scientific research and studies, that you provided to substantiate the claims made for your “Vitamin O” products. In addition, we reviewed your websites at the following Internet addresses: http://www.rgarden.com, http://www.rgarden.net, http://rgarden10.net. Our review of the information collected during the inspection and your websites found numerous violations of the Federal Food, Drug, and Cosmetic Act (the Act). You can find the Act and FDA’s regulations through links on FDA’s Internet web site at www.fda.gov.

Under section 201(g)(1)(B) of the Act (21 U.S.C. 321(g)(1)(B)), articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease are drugs. Based on claims that appear on your website for R-Garden, Inc., including claims in the form of testimonials, and in literature you distribute in each product shipment for both R-Garden, Inc., and Rose Creek Health Products, Inc., we have determined that your “Vitamin O” products arc promoted for conditions that cause the products to be drugs under section 201(g)(1)(B). The therapeutic claims on your websites and in your promotional material establish that the products are drugs because they are intended for use in the cure, mitigation, treatment or prevention of disease.

Examples of some of the claims observed in your health newsletters, which are distributed with each individual shipment of R-Garden, Inc., and Rose Creek Health Products, Inc. “Vitamin O” products, include:

Examples of some of the claims observed in product descriptions on your website for R-garden, Inc, "Vitamin O" include:

Examples of some of the claims observed in testimonials for R-Garden, Inc., "Vitamin O" from your websites include:

Examples of some of the claims observed in testimonials from the booklet “Fruits of R-Garden Internationale Testimonials,” which is distributed with each individual shipment of R-Garden, Inc., and Rose Creek Health Products, Inc. “Vitamin O” products, include:

Because these products are not generally recognized as safe and effective when used as labeled, they are also new drugs as defined in section 201(p) of the Act [21 U.S.C. 321(p)}. Under section 505 of the Act (21 U.S.C. 359, anew drug may not be legally marketed in the United States without an approved New Drug Application (NDA). Your Vitamin O products are also misbranded under section 502(f)(1) of the Act, in that the labeling does not bear adequate directions for use.

R-Garden, Inc. “Vitamin O Spray,” and Rose Creek Health Products, Inc., “Vitamin O Spray Stabilized Oxygen Molecules,” although labeled as dietary supplements, are intended for use as topical sprays for use on the skin and in the ears and nose. Under section 201(ff)(2)(A)(i) of the Act [21 U.S.C. 321(ff)(2)(A)], the term “dietary supplement” is defined as, among other things, a product “intended for ingestion.” Products that are intended to be used topically or introduced into the body other than through ingestion are not dietary supplements because they are not “‘intended for ingestion.” In addition to the disease claims stated above that cause these products to be drugs, they also appear to be drugs under 21 U.S.C. 321(g)(1)(C) because they are articles (other than food) intended to affect the structure or function of the body. Examples of claims that your products affect the structure or function of the body are listed in the following section.

Substantiation

Even if your Vitamin O products that are intended for ingestion did not bear claims that cause them to be drugs, as dietary supplements they would violate other provisions of the Act. Your R-Garden, Inc. and Rose Creek Health Products, Inc., “Vitamin O” products are misbranded under sections 403(r)(6)(B) and 403(a)(1) of the Act [21 U.S.C. 343(r)(6)(B) and 343(a)(1)] because the products’ labeling includes unsubstantiated claims. Under the Act, dietary supplements may be legally marketed with claims to affect the structure or function of the body (structure/function claims), if certain requirements are met [21 U.S.C. 343(r)(6); 21 C.F.R. 101.93(f)]. The manufacturer of a dietary supplement containing a “structure/function” claim in the product’s labeling must have substantiation that the claim is truthful and not misleading [see 21 U.S.C. 343(r)(6)(B)]

Product labels for R-Garden, Inc. “Stabilized Vitamin O” and “Vitamin O” state “[i]n double blind clinical studies involving blood gas analysis, Vitamin O has been shown to significantly increase blood oxygen levels.” In the product brochure “R-Garden Products for the Garden Within Us”, which is distributed with all R-Garden, Inc. and Rose Creek Health products, Inc. Vitamin O product shipments, it states “[i]n a 6-month double-blind study, those taking Vitamin O showed a 17% to 32% increase in arterial blood oxygen! In oral interviews conducted during this study, research participants reported greater youthfulness, improved mobility, better circulation, sharper mental clarity, enhanced lung and heart function, and increased physical energy.”

We have reviewed these claims, along with the substantiation package you provided during the inspection, and concluded that they are not supported by competent and reliable scientific evidence. Because these claims lack substantiation, they are false or misleading, and cause your product to be misbranded within the meaning of section 403(a)(1) and 403(r)(6)(B) of the Act [21 U.S.C. 343(r)(6)(B) and 343(a)(1)].

Labeling

The product R-Garden, Inc. “Stabilized Vitamin O,” 16 Fl. Oz, is misbranded under sections - 403(i)(1) and 403(s)(2)(B) of the Act [21 U.S.C. 343(i)(1) and 343(s)(2)(B)] because the label fails to identify the product with the term “dietary supplement” (or an appropriate alternative authorized by regulation) as part of the statement of identity, on the principal display panel, as specified in 21 CFR 101.3(d) and (g).

Your “Vitamin O” products that are intended for ingestion are further misbranded under Section 403(q)(5)(F) of the Act in that the nutrition information in their labeling fails to meet the requirements of 21 CFR 101.36.

The following are examples:

This letter is not intended to be an all inclusive review of your products and labeling. It is your responsibility to ensure that all products marketed by your firm comply with the Act and its implementing regulations.

We request that you take prompt action to correct these violations. Failure to immediately cease distribution of your violative products could result in enforcement action by FDA without further notice. The Act provides for the seizure of illegal products, injunctions against the manufacturers and/or distributors of violative products, and criminal sanctions against persons responsible for causing violations of the Act.

Please notify this office in writing within fifteen (15) working days of the receipt of this letter as to the specific steps you have taken to correct these violations, including any steps taken with respect to violative products currently in the marketplace, and an explanation of each step taken to assure that violations do not recur. Your reply should be sent to the Food and Drug Administration, Attention: Lisa Althar, Compliance Officer, 22201 23rd Drive SE, Bothell, Washington 98021-4421.

Sincerely,

/s/

Charles M. Breen
District Director

This page was posted on March 29, 2005.

Links to Recommended Companies